Respiratory syncytial virus, interleukins

De Swart LT, Kuiken T, Timmerman HH, van Amerongen G, Van den Hoogen B, Vos HW, Neijens HJ, Andeweg AC, Osterhaus A. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13 associated hypersensitivity to subsequent RSV infection. / Virol. 2002 76(22) 11561-11569. 

Black HR, Yankaskas JR, Johnson LG, Noah TL. Interleukin-8 production by cystic fibrosis nasal epithehal cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. Am J Respir Cell Mol Biol 1998 19 210. 

Takeuchi R, Tsutsumi H, Osaki M et al. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-lbeta-converting enzyme gene expression but does not cause apoptosis. J Virol 1998 72(5) 4498-502. 

Mastronarde JG, Monick MM, Mukaida N et al. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998 177(5) 1275-81. 

Garofalo R, Sabry M, Jamaluddin et al. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J Virol 1996 70(12) 8773-81. 

Thomas LFF, Wickremasinghe MI, Sharland M et al. Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection. J Virol 2000 74(18) 8425-33. 

Arnold R, Humbert B, Werchau H et al. Interleukin-8, interleukin-6, and soluble tumor necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994 82(l) 126-33. 

Johnson TR, Graham BS. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J Virol 1999 73(10) 8485-95-... 

Johnson TR, Johnson JE, Roberts SR et al. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol 1998 72(4) 2871-80. 

Connors M, Giese NA, Kulkarni AB et al. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 1994 68(8) 5321-5. 

Oh, J. W., Lee, H. B., Park, I. K., and Kang, J. O. (2002). Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr. Allergy Immunol. 13, 350. 

Smyth, R. L., Mobbs, K. J., O Hea, U., Ashby, D., and Hart, C. A. (2002). Respiratory syncytial virus bronchiolitis Disease severity, interleukin-8, and virus genotype. Pediatr. Pulmonol 33, 339. 

---